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NEWS & NOTES
Conference Summary
National Antibiotic
Resistance
Monitoring System
for Enteric Bacteria 
National Antibiotic Resistance
Monitoring System (NARMS)–
enteric bacteria is a collaboration by
the Centers for Disease Control and
Prevention (CDC), the U.S. Food and
Drug Administration, the Center for
Veterinary Medicine (FDA-CVM),
and the U.S. Department of
Agriculture, Agricultural Research
Services (USDA-ARS). NARMS was
established in 1996 and monitors
antimicrobial drug resistance in
Campylobacter,  Escherichia coli
O157:H7,  Enterococcus, non-Typhi
Salmonella,  Salmonella Typhi, and
Shigella.
The 2004 meeting was held March
4–5 in Decatur, Georgia, and hosted
by the Foodborne and Diarrheal
Diseases Branch, Division of
Bacterial and Mycotic Diseases,
National Center for Infectious
Diseases, CDC. The meeting high-
lighted data from scientific studies
and surveillance for antimicrobial
drug resistance in the United States
and abroad with enteric bacteria iso-
lated from humans, animals, and retail
foods. Approximately 180 partici-
pants from 14 countries, representing
71 organizations, attended the meet-
ing. The organizations included inter-
national and national public health
agencies, state and local health
departments, public health laborato-
ries, industry consumer groups, and
academic institutions from Australia,
Canada, Cameroon, China, Denmark,
Europe, Italy, Japan, Philippines,
Poland, Thailand, the United
Kingdom, the United States, and
Vietnam.
The meeting began with a World
Health Organization expert’s summa-
rization of a recent workshop on non-
human antimicrobial drug use and
antimicrobial drug resistance.
Scientific assessment and risk man-
agement of antimicrobial drug use in
agriculture and human and veterinary
medicine were examined. A plenary
session on the human health conse-
quences of antimicrobial drug resist-
ance consisted of two presentations
from the United States and two pre-
sentations from Denmark.
The results of a study conducted
by CDC that found higher rates of
hospitalization and death in resistant
Salmonella infection, as compared to
susceptible ones, were presented. The
results of another CDC study that
found higher frequencies of blood-
stream infection and hospitalization
with resistant Salmonella infections,
as compared to susceptible ones, were
presented. A presentation from the
Statens Serum Institut in Denmark
highlighted the association between
flouroquinolone-resistant  Campylo-
bacter infections, as compared to sus-
ceptible ones, and a higher frequency
of invasive illness, hospitalization,
and death. A second presentation
demonstrated increased death rates in
resistant  S. Typhimurium infections,
as compared to susceptible ones.
Other speakers highlighted emerging
resistance to clinically important
antimicrobial drugs, environmental
studies on antimicrobial drug resist-
ance, antimicrobial drug resistance in
commensal bacteria, partner perspec-
tives on antimicrobial drug resistance,
international perspectives on antimi-
crobial drug resistance, and NARMS
educational activities. A presentation
of the “GET SMART: Know When
Antibiotics Work on the Farm” cam-
paign highlighted educational efforts
to promote the appropriate use of
antibiotics in veterinary medicine.
The campaign currently includes an
interactive Web-based program on
aspects of microbiology, pharmacolo-
gy, infectious disease, and public
health for veterinary students and vet-
erinarians who participate in continu-
ing education programs. The confer-
ence also included brief summaries of
three recent outbreaks of multidrug-
resistant  S.  Typhimurium DT104 R-
type, which has become a common
strain of Salmonella isolated from
humans and was resistant to ampi-
cillin, chloramphenicol, streptomycin,
sulphonamides, and tetracyclines.
More information about NARMS and
antimicrobial resistance can be found
at www.cdc.gov/NARMS.
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